Deterra Royalties

Phase A — Understand the business

Lens 1 · Company Overview

Deterra Royalties is Australia's largest ASX-listed, resources-focused royalty company — a pure-play royalty holder, not a miner. It owns the right to a slice of other companies' mining revenue and bears almost none of the operating or capital cost. It was spun out of Iluka Resources in November 2020, carrying with it one cornerstone asset: the Mining Area C ("MAC") royalty over BHP's iron-ore province in the Pilbara, Western Australia.

How it actually makes money — the MAC royalty (the whole company, ~90%+ of revenue):

• A 1.232% ad-valorem royalty on the A$-denominated revenue from iron ore sold out of the MAC royalty tenements, operated by BHP (with JV partners Itochu and Mitsui). This is a top-line royalty — Deterra is paid on BHP's revenue before BHP's costs, so margin compression at the mine never touches Deterra's cut.
• Plus capacity payments: a one-off A$1.0m per million dry tonnes of new record annual production above the previous high-water mark, measured over any 12 months to 30 June. This is the growth kicker that has now largely run its course (see Lens 4/13).

The economics are extraordinary because the cost base is a small Perth office. FY25 underlying EBITDA margin was effectively ~95% and ROE 65.7%. There is no mine to run, no capex to fund, no orebody to deplete on Deterra's books — BHP carries all of it.

The second act — diversification via Trident (Sept 2024): Recognising that a single-asset, single-commodity royalty is a terminal-value problem (iron ore is mature; MAC tonnage is plateauing), Deterra acquired UK-listed Trident Royalties (AIM: TRR) for £144m (~A$250m), 49p/share, all-cash, completed 2 Sept 2024. This bolted on 22 royalty / royalty-like offtake assets across 11 countries and six commodities (lithium, copper, silver, gold, iron ore, mineral sands). The crown jewel is a lithium royalty over Thacker Pass (Lithium Americas, Nevada — see Lens 2/4). Deterra then sold the non-core gold assets (to Vox Royalty, ~US$60m) and used proceeds to cut acquisition debt.

Customers / counterparties: Deterra has essentially one customer that matters — BHP (via the MAC royalty), plus a long tail of small royalty payers from Trident (Lithium Americas, Mimbula/copper, La Preciosa/silver). Concentration is the defining feature of the business and the central risk (Lens 13).

Lens 2 · Supply Chain

Deterra sits off to the side of the mining value chain — it touches no ore — but its cash flows are wired to specific operators. The map, with named stakeholders:

MAC iron-ore chain (the cash engine):

• Orebody / operator: BHP operates Mining Area C in the Pilbara; JV partners Itochu and Mitsui hold economic interests.
• The South Flank expansion lifted MAC from ~60Mtpa (2019) to a combined nameplate of ~145Mtpa wet via the South Flank deposit, which reached and exceeded its 80Mtpa nameplate in FY25; the expansion was essentially complete by end-June 2025. MAC is described as the largest operating iron-ore hub in the world, 45+ years of mine life.
• End buyers: Chinese steel mills, predominantly. BHP ships seaborne iron ore to China; a pricing standoff between BHP and China's state-backed CMRG is an active 2026 overhang on realised prices.
• Deterra's node: receives 1.232% of A$ MAC revenue + capacity payments. Single-source dependency: there is no second iron-ore royalty of comparable size. If BHP curtails MAC, there is no substitute.

Thacker Pass lithium chain (the future option):

• Operator: Lithium Americas Corp (LAC); General Motors is a strategic backer/offtaker; the project secured a US$2.26bn financing package to fund Phase 1.
• Deterra's node: a 4.8% gross-revenue royalty, reducing to 1.05% after a partial buyback (LAC pays Deterra US$13.2m to exercise). First production from Phase 1 expected late 2027; ultimate target 160ktpa LCE across four 40ktpa phases.

Other Trident-derived royalties (small): Mimbula copper (Zambia), La Preciosa silver (Mexico), plus a residual mineral-sands and base-metals tail. None individually material today.

Chokepoint summary: the entire enterprise value rests on one chokepoint — BHP's willingness and ability to keep MAC running at ~145Mtpa, sold into a China-dominated steel market. Diversification has begun but is years from moving the revenue mix.

Lens 3 · Competitive Advantages (moats)

Deterra's moat is structural and contractual, not operational — and it is genuinely wide on the existing assets, but does not extend to winning new ones.

• The MAC royalty is a perpetual, top-line claim on a tier-1, lowest-quartile-cost orebody. Morningstar has repeatedly tagged Deterra as its "only wide-moat ASX miner". The moat is the contract: 1.232% of revenue off the world's largest iron-ore hub, with 45+ years of reserve life, no recompete, no capex call, no cost exposure. That is as close to a bond-with-upside as mining offers.
• Capital-light, ungeared cash conversion. ~95% EBITDA margin, 65.7% ROE — economics no operating miner can match. Deterra converts commodity revenue to franked dividends with almost no leakage.
• Bargaining power is asymmetric — and against Deterra on new deals. Over BHP it has none (the royalty is fixed and already signed); BHP needs Deterra not at all. As a buyer of new royalties, Deterra competes with deep-pocketed global peers (Franco-Nevada, Wheaton, Triple Flag, Vox) for scarce assets — so its growth moat is weak. It paid up for Trident and is hunting A$100–500m deals into a competitive market.
• What the moat does NOT protect: growth. The MAC moat is wide but non-extensible — once tonnage plateaus, the royalty becomes a slowly-declining (with iron-ore price) annuity. The franchise's durability is high; its growth optionality depends entirely on capital allocation into new royalties, where it has no edge over larger peers.

Lens 4 · Segments

No segments.csv exists (web-only). Revenue is overwhelmingly one segment, one geography:

The segment story in numbers:

• FY25: revenue A$263.4m, +9.5% YoY (FY24 A$240.5m). But the composition matters: MAC royalty revenue fell ~8% YoY on lower realised iron-ore prices, offset by record MAC volumes (140.1Mwmt), a ~A$20m capacity payment, and the new ~A$22.6m Trident contribution. So headline growth was almost entirely capacity-payment + acquisition, not underlying royalty strength.
• H1 FY26 (half to Dec-2025): record statutory NPAT A$87.2m (+36%); underlying NPAT A$75.7m (+20%); EBITDA A$121.7m (+29%); MAC sales a record 68Mt dry @ realised A$139/t (+5% vs H1 FY25); MAC royalty revenue +12%. Note: part of the statutory beat was a one-off gain on the gold-asset disposal, not recurring royalty income.

The crucial segment trend — capacity payments are rolling off. South Flank's ramp is complete, so the "A$1m per new record Mt" kicker shrinks toward zero once production stops setting fresh highs. FY23 capacity payment ~A$13.0m; FY25 ~A$20m; JPMorgan cut FY26 NPAT on lower expected MAC capacity payments. The growth engine of the last few years is decelerating by design.

---

Phase B — Measure performance

Lens 5 · Earnings Result (latest print: H1 FY26, reported Feb 2026)

The headline was a record — but read the quality.

• Statutory NPAT A$87.2m, +36% YoY. Underlying NPAT A$75.7m, +20% — the gap is the gold-disposal gain.
• EBITDA A$121.7m, +29%; revenue growth driven by record MAC volumes (68Mt dry, H1) and realised price A$139/t (+5%); MAC royalty revenue +12%. (A separate source cites H1 FY26 MAC production of 72.6Mt, +6% YoY — production vs. sales timing difference.)
• Margins: net margin 65.7% — a royalty company's signature.
• Guidance / outlook: FY26 MAC cost guidance A$18.25–19.75/t of operating cost at the mine (informs the royalty base, not Deterra's own costs); MAC backed by 145Mtpa capacity, 45+ yr life. Street FY26 consensus ≈ revenue A$228m, EBITDA A$211m, NPAT A$140m. Note the FY26 NPAT consensus (~A$140m) is BELOW FY25 underlying NPAT (~A$160m) — the Street expects a down year as capacity payments fade and iron-ore prices soften.
• Balance sheet flag (positive): received A$108m cash from non-core precious-metals disposals, deployed to reduce the Trident acquisition debt; leverage low (FY25 ~10%).
• Dividend: interim A$0.124/share, fully franked, 75% payout maintained.
• Market reaction: muted-to-positive; the stock sits ~A$4.41 (Jun-2026), roughly mid-range of its 12-month band — the record half did not trigger a rerate, because the market correctly reads it as price/one-off-driven against a fading volume kicker.

Unusual vs. own history: the statutory/underlying NPAT divergence (disposal gain) and the fall in core MAC royalty revenue in FY25 despite record volumes are the two things to flag — both say "this is an iron-ore-price story dressed as a volume story."

Lens 6 · Earnings Calls (sentiment trend)

No transcripts/ on disk; this is web-derived from call summaries (FY25 Aug-2025 call; H1 FY26 Feb-2026 call).

What management keeps saying (the through-line):

• "Disciplined capital allocation" — target leverage 0–15%, 75% payout, retain 25% to pay down the Trident facility, "at least A$300m of dry powder" for new royalties in the A$100–500m range, focused on lithium and copper.
• "We are a pure-play on base, bulk and electrification minerals" — the post-Trident identity. Gold is explicitly non-core ("assess where the gold offtakes fit," → divested).

What shifted in tone:

• The dividend message hardened. After cutting the payout from 100% to a minimum 50% target in June 2024 (to fund diversification), the interim CEO was explicit on the H1 FY26 call: "going back to 100% payout is not on the horizon — investors should not expect that". The income-stock thesis has been permanently re-based.
• CEO succession is an open thread — opex rose 27% on CEO succession costs; the company is recruiting a permanent CEO. Tone is "transition," which adds execution uncertainty to the M&A-led growth plan.

What they stopped saying: the original "100% payout, pure iron-ore yield" pitch is gone. The narrative is now "growth-and-diversification royalty company," which is a harder, more capital-allocation-dependent story to underwrite.

Lens 7 · Comps

Royalty companies trade on yield and NAV, not P/E like operators — and Deterra is the odd one out: an iron-ore royalty among precious-metals streamers, so the multiples are not clean comparables. Provenance-critical — multiples are `` with date, or n/a.

Read: Deterra screens cheap on P/E and rich on yield versus the precious-metals royalty cohort (FNV/WPM/TFPM trade 28–66x fwd P/E and <1% yields because the market prizes gold's perpetual, inflation-hedge NAV). The gap is not mispricing — it is asset-class: iron ore is a depleting, cyclical, China-levered bulk with a plateauing volume profile, so it earns a lower multiple and must pay a fat yield to compensate. The "forward P/E ~21.6x" against "trailing ~12.9x" correctly signals the Street's expectation of a down earnings year (capacity payments fading, iron-ore softening). There is no pure DRR peer — the cleanest read is on NAV/yield, where JPMorgan pegs it at P/NPV ~0.97x = fairly valued. The headline "24.3% dividend yield" in one Kalkine piece is a data artifact (almost certainly a trailing special-distribution distortion or feed error) — the real forward yield is ~5–6%; flagged, not used.

Lens 8 · Stock-Price Catalysts (the >5% movers, last ~5 years)

DRR is, in effect, a leveraged play on the iron-ore price and on its own dividend policy. The pattern from the record:

• The iron-ore price is the dominant driver. Iron ore started 2024 ~US$130/t and fell to ~US$90 by early 2025; DRR's de-rating tracked it. The royalty is a direct 1.232% claim on iron-ore revenue, so DRR moves with the spot/contract price far more than with any company-specific news.
• The June-2024 dividend cut (100%→min 50%) + Trident announcement was a major negative catalyst — the income base re-rated lower in a single decision.
• Capacity-payment prints (the annual "new record tonnage" payment) and MAC quarterly volume updates move the stock at the margin.
• Analyst actions: JPMorgan downgraded on valuation (P/NPV ~0.97x); Morgan Stanley upgraded to Buy, target A$4.75. Consensus 12-month target ~A$4.55–4.65 (range A$3.95–5.50), Buy, ~13% upside to ~A$4.41.
• What the market reacts to: iron-ore price >> dividend policy > capacity payments > lithium/Thacker-Pass milestones (still an option, not yet cash) > M&A. It does NOT react much to "record volumes" — because volumes are plateauing and the price is what's swinging.

---

Phase C — Judge people & books

Lens 9 · Management

• Track record / archetype — professional managers, not founders. Deterra is a 2020 demerger run by a professional team. Julian Andrews (Managing Director/CEO since the 2020 spin-out) has 25+ years in project finance, capital raising and M&A across mining/energy/chemicals. He led the Trident acquisition and the subsequent gold-asset clean-up — a coherent, value-aware capital-allocation sequence (buy diversified, sell the non-core, pay down debt). Board: 5 directors, independent chair, 40% female.
• Skin in the game: no insider-transactions.csv on disk; insider ownership not sourced — n/a. As a demerger (not a founder-owned vehicle), insider alignment is likely modest; flag for follow-up.
• Capital-allocation history (the core competency for a royalty co): Good. Maintained an ungeared, high-payout balance sheet; made one sizeable, strategically-logical acquisition (Trident, ~A$250m) at a disciplined cash price; immediately monetised the non-core gold (~A$108m proceeds) and deleveraged; set a clear framework (75% payout, 0–15% leverage, A$100–500m deal size, lithium/copper focus, ~A$300m dry powder). ROE 65.7% reflects the model more than management genius, but they have not destroyed capital — the cardinal royalty-company sin.
• Red flags: (1) CEO succession in progress — opex +27% on succession costs; leadership transition during an M&A-led growth phase is an execution risk. (2) The dividend cut was shareholder-unfriendly optics even if strategically right — it broke the original income contract. (3) Risk of "di-worsification" — pressure to deploy A$300m of dry powder into smaller, lower-quality royalties to manufacture growth (see Lens 13).
• Verdict on management: competent, disciplined capital allocators executing a sensible-but-hard pivot from single-asset annuity to diversified royalty platform. The judgement risk is future deals, not past ones.

Lens 10 · Forensic Red Flags

A royalty company has a structurally simple, low-forensic-risk income statement — revenue is a contractual % of a counterparty's sales, costs are negligible, there is no inventory, no large receivables build, no revenue-recognition gymnastics, no goodwill-laden roll-up (Trident was the only acquisition). That said:

• Statutory vs. underlying NPAT divergence — watch the adjustments. FY25 statutory NPAT A$155.7m vs. underlying A$160.3m; H1 FY26 statutory A$87.2m vs. underlying A$75.7m. The H1 FY26 statutory > underlying gap is the one-off gold-disposal gain — legitimately excluded from underlying, but it means the record statutory print overstates recurring earning power. Anyone anchoring on "A$87.2m, +36%" is double-counting a non-recurring sale.
• Effective tax rate noise: FY25 ETR 30.8%, elevated by non-deductible Trident transaction costs — a one-off, not a structural drag; normalises to ~30% (Australian corporate rate).
• Goodwill / intangibles: the Trident purchase price allocation (royalty intangibles) is the only place impairment risk lives — if lithium/copper royalty assets underperform (e.g., Thacker Pass slips or lithium prices stay low), expect intangible write-downs. Not yet flagged, but the asset to watch. Magnitude n/a (PPA detail not in web summaries).
• Cash vs. earnings: for a royalty co, cash flow should track earnings tightly (no working-capital drag). Reported deleveraging from disposal proceeds is consistent with clean cash conversion; no divergence flagged in summaries.
• Dividend sustainability: 75% payout of a cyclical royalty stream means the dividend floats with the iron-ore price — not a forensic red flag, but the dividend is not a fixed coupon; a sharp iron-ore fall cuts it proportionally.

Regulatory findings (required sub-section).

• SEC EDGAR (LR + AAER): regulatory/regulatory-findings.md records total_sec_findings: 0 — Deterra has no CIK and is not an SEC registrant, so no EDGAR enforcement search is possible.
• Non-SEC web search ("Deterra Royalties" (FTC OR DOJ OR FDA OR CFPB OR consent decree OR settlement OR fine OR penalty) enforcement): no material enforcement actions, fines, or consent decrees surfaced across the searches run for this dossier. As an ASX-listed royalty holder with no mining operations, its regulatory surface (environmental, native-title, mine-safety) is borne by operators (BHP, LAC), not Deterra.
• Item 3 / Legal Proceedings: no 10-K exists (ASX filer). The equivalent ASX annual-report legal-proceedings disclosure was not on disk; web summaries surfaced no material litigation.
• Conclusion: No material regulatory or legal findings — verified via SEC EDGAR EFTS (LR, AAER, zero — non-registrant), web search across FTC/DOJ/FDA/CFPB-style enforcement, and available 2025–26 disclosures, as of 2026-06-29. (ASX-specific continuous-disclosure record not independently inspected — flagged as an open item.)

---

Phase D — Project & stress-test

Lens 11 · Forward Projection (EPS, next three fiscal years — FY26/FY27/FY28, June year-ends)

Anchors (all /): ~529.5m shares. FY25 underlying NPAT ~A$160m → underlying EPS ~A$0.30. FY26 Street consensus NPAT ~A$140m → EPS ~A$0.265. Key swing variables: iron-ore price (consensus ~US$95/t 2026, sub-US$100 H2-26, falling into 2027 per World Bank/INN ), AUD/USD, MAC volumes (plateaued ~140–145Mt), capacity payments (fading to ~0), Thacker Pass (no cash until late-2027).

Shape of the call: base case is a gently declining EPS (A$0.30 FY25 → ~A$0.265 FY26 → ~A$0.25 FY27/28) — the franchise earns less, not more, over the next three years unless iron ore surprises up or M&A adds a new stream. The dividend (75% payout) follows EPS down in the base/bear paths. The bull case is entirely iron-ore-price + capital-allocation driven, not organic. This is a yield-and-NAV name, not a compounder.

Per --watchlist rules, no forecast.ts create is logged in this loop. Base-case Brier candidate for a later pass: "DRR.AX FY26 underlying EPS ≥ A$0.26" (p≈0.55), resolves 2026-06-30 — note for Connor, not logged.

Lens 12 · Bull vs Bear

Bull case. Deterra is the highest-quality, lowest-risk way to own iron-ore cash flow on the ASX — a perpetual 1.232% top-line royalty over the world's largest, lowest-cost, 45-year-life iron-ore hub, run by BHP, with ~95% margins, 65.7% ROE, ~zero capex, near-zero leverage, and a fully-franked ~5–6% yield. The balance sheet is fortress (deleveraged with A$108m of disposal proceeds), and there is ~A$300m of dry powder plus a free lithium option (Thacker Pass, 4.8%→1.05% royalty over North America's largest lithium deposit, GM-backed, first cash ~late-2027) that the market is paying almost nothing for. If iron ore holds and management lands one good copper/lithium royalty, the diversification story rerates the multiple toward its precious-metals peers. The contrarian bull point: the market is treating DRR as a melting iron-ore ice cube and ignoring that it is quietly becoming a diversified royalty platform with the cleanest balance sheet in the sector.

Bear case (the two things that permanently matter).

1. It is one tonnage stream into a structurally softening, China-controlled iron-ore market — and the volume kicker is over. MAC is plateaued at ~145Mtpa, so the capacity payments (the growth of the last 4 years) roll to ~zero. From here, MAC revenue is price × flat-volume × 1.232% — and the price outlook is down: World Bank/INN see iron ore averaging ~US$95/t in 2026, below US$100 in H2, falling below 2019 levels into 2027, with Simandou (Guinea) adding 40–50Mt of new supply by 2027 and the BHP–CMRG pricing standoff capping realisations. The core asset is a declining annuity, not a growth engine.
2. The growth pivot requires winning competitive M&A — where Deterra has no edge — and the dividend has already been cut once to fund it. To offset MAC's plateau, Deterra must deploy A$300m+ into royalties it must outbid Franco-Nevada/Wheaton/Triple Flag to win, risking overpayment or di-worsification into smaller, lower-quality assets. The 100%→75% payout cut already broke the income contract; management says 100% isn't coming back.

Pre-mortem (18 months out, thesis broke): iron ore fell to ~US$75–80/t on Simandou supply + weak China steel; MAC capacity payments hit zero; FY27 EPS prints ~A$0.20; the dividend (75% payout) was cut ~20%; the lithium option stayed worthless (Thacker Pass slipped / lithium price stayed depressed); and management, under pressure to "show growth," overpaid for a mid-quality copper royalty — the stock de-rated to ~A$3.50 on a lower NAV and a lower multiple.

Are multiples too high? No — fairly valued. JPMorgan's P/NPV ~0.97x is the right frame: the stock is not cheap on NAV, the trailing P/E (~13x) flatters because FY26 earnings fall, and the forward P/E (~21.6x) is honest. You are paid a ~5–6% franked yield to wait, but there is no margin of safety baked into a rerate at A$4.41.

Contrarian view (what the market refuses to see): the bears over-index on "iron ore is dying" and miss that Deterra has already executed the hardest part of the pivot cleanly (bought diversified, sold non-core, deleveraged) and holds a genuinely cheap embedded lithium call — so the downside is well-protected by the yield and the balance sheet even if the upside needs iron ore or M&A to show up. It is a low-beta "get-paid-to-wait" royalty, not a melting ice cube — but also not a compounder. The market's ~A$4.55 target (≈fair) is, for once, about right.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull case:

• Revenue concentration is near-total and one-way. ~90%+ of revenue is one royalty, one commodity, one operator (BHP), one end-market (China steel). If China's steel demand has structurally peaked (property never recovers; Simandou floods the seaborne market), the price leg of a 1.232% top-line royalty compounds downward with no volume offset — because volume is already maxed at 145Mtpa. There is no diversification that matters for at least 2–3 years.
• The "capacity payment" growth was always a one-off, and it's done. Bulls cite "record results," but the record was South Flank's ramp-driven capacity payments (A$13m→A$20m) plus a non-recurring gold-disposal gain — neither repeats. Strip both and you have a flat-to-declining iron-ore royalty. FY26 consensus NPAT (~A$140m) is below FY25 (~A$160m) — the Street already knows.
• The moat is wide but inert; the growth moat is non-existent. Deterra cannot create new MAC royalties; it must buy them, competing against Franco-Nevada/Wheaton (10–40x the firepower). The most dangerous "competitor" is therefore the auction market for royalty assets — Deterra either overpays (NPV-dilutive) or under-deploys (the dry powder earns nothing). Trident was fine; the next deal, done under CEO-transition and growth-pressure, is the risk.
• Worst capital-allocation moves? None catastrophic yet — but the dividend cut to fund Trident broke the original thesis, and the open question is whether A$300m of dry powder gets spent well or chases growth for growth's sake.
• What must hold for A$4.41? Iron ore ~US$90–95/t, AUD contained, MAC at ~140Mt, the 75% dividend intact, and some credit for the lithium option. If iron ore disappoints 20–30% (to ~US$65–70/t): royalty revenue falls ~20–30%, EPS toward ~A$0.18–0.20, the dividend cuts proportionally, and the stock re-rates to ~A$3.00–3.50 on a lower NAV. There is no balance-sheet break (ungeared), so it's a de-rate, not a blow-up — but a 25–30% drawdown is entirely plausible on the iron-ore cycle alone.
• Single scenario that permanently impairs: a structural, sustained collapse in seaborne iron-ore prices (China steel demand down 15–20% structurally + Simandou supply) that makes parts of MAC sub-economic for BHP and compresses the royalty base for years. Plausibility: moderate — not a base case, but the central long-term risk, and the entire reason this is a high-yield, low-multiple stock rather than a Franco-Nevada-style compounder.

Lens 14 · Management Questions (ordered by information value)

1. With South Flank's ramp complete, what is your explicit FY27–FY30 expectation for MAC capacity payments — do you model them as effectively zero, and what MAC tonnage assumption underpins base-case royalty revenue?
2. What iron-ore price and AUD/USD assumptions sit behind your internal NAV, and at what sustained iron-ore price does the 75% dividend get cut?
3. Of the ~A$300m dry powder, what is your hard discipline on price — what maximum P/NAV (or minimum IRR) will you pay for a new royalty, and would you return capital rather than overpay?
4. On the next acquisition: lithium vs. copper — which, why, and how do you avoid di-worsification into smaller, lower-quality assets to manufacture growth?
5. CEO succession — what is the timeline, the candidate profile (royalty/M&A vs. mining operator), and how do you prevent the transition from forcing a rushed deal?
6. Thacker Pass: what realised lithium price and ramp schedule make the 1.05% royalty material to group revenue, and in what year do you expect first cash — late 2027 still firm?
7. Would you exercise or decline participation in the Thacker Pass royalty buyback (US$13.2m to LAC), and what does that decision say about your lithium-price view?
8. How exposed is the MAC royalty base to the BHP–CMRG pricing standoff and any shift to yuan-denominated / index-decoupled iron-ore pricing?
9. What is the realistic timeline for non-iron-ore royalties to reach >25% of revenue, and is that achievable organically or only via a transformational acquisition?
10. How do you think about share buybacks versus acquisitions when the stock trades near or below your own NAV (P/NVP ~0.97x)?
11. What impairment risk sits in the Trident royalty intangibles if lithium/copper prices stay depressed through 2027?
12. What is insider ownership across the board and executive team today, and how is management compensation tied to per-share NAV growth rather than asset count or AUM?
13. Beyond MAC, what is your counterparty-risk framework — how concentrated can a single new royalty payer become before it's a board-level concern?
14. What would make you walk away from the diversification strategy and return to a high-payout, iron-ore-focused capital-return vehicle?
15. If iron ore averaged US$70/t for three years, what does Deterra look like — dividend, balance sheet, and strategy — and what is your contingency?

---